Terms: = Kidney tumors AND TLX3, O43711, 30012, ENSG00000164438, HOX11L2, RNX AND Treatment
2 results:
1. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS; Abello A; Nguyen J; Lee AJH; Desloges JJ; Leapman MS; Kenney PA
World J Urol; 2020 May; 38(5):1187-1193. PubMed ID: 31420696
[TBL] [Abstract] [Full Text] [Related]
2. Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.
Gore ME; Griffin CL; Hancock B; Patel PM; Pyle L; Aitchison M; James N; Oliver RT; Mardiak J; Hussain T; Sylvester R; Parmar MK; Royston P; Mulders PF
Lancet; 2010 Feb; 375(9715):641-8. PubMed ID: 20153039
[TBL] [Abstract] [Full Text] [Related]
